|Head and neck cancer|
A Argiris, MV Karamouzis, D Raben, RL Ferris
The Lancet 371 (9625), 1695-1709, 2008
|Carboplatin and paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non–small-cell lung cancer|
SS Ramalingam, ML Maitland, P Frankel, AE Argiris, M Koczywas, ...
Journal of clinical oncology 28 (1), 56, 2010
|Swallowing dysfunction—preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review|
BB Mittal, BR Pauloski, DJ Haraf, HJ Pelzer, A Argiris, EE Vokes, ...
International Journal of Radiation Oncology• Biology• Physics 57 (5), 1219-1230, 2003
|Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas|
MV Karamouzis, JR Grandis, A Argiris
Jama 298 (1), 70-82, 2007
|Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignancies|
SS Ramalingam, RA Parise, RK Ramananthan, TF Lagattuta, ...
Clinical cancer research 13 (12), 3605-3610, 2007
|Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy|
A Argiris, BE Brockstein, DJ Haraf, KM Stenson, BB Mittal, MS Kies, ...
Clinical cancer research 10 (6), 1956-1962, 2004
|The impact of health insurance status on the survival of patients with head and neck cancer|
J Kwok, SM Langevin, A Argiris, JR Grandis, WE Gooding, E Taioli
Cancer: Interdisciplinary International Journal of the American Cancer …, 2010
|Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial|
A Argiris, M Ghebremichael, J Gilbert, JW Lee, K Sachidanandam, ...
Journal of clinical oncology 31 (11), 1405, 2013
|Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck: An analysis of two Eastern Cooperative Oncology Group …|
A Argiris, Y Li, A Forastiere
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
|CTLA-4+ regulatory T cells increased in cetuximab-treated head and neck cancer patients suppress NK cell cytotoxicity and correlate with poor prognosis|
HB Jie, PJ Schuler, SC Lee, RM Srivastava, A Argiris, S Ferrone, ...
Cancer research 75 (11), 2200-2210, 2015
|Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples|
A Kotsakis, M Harasymczuk, B Schilling, V Georgoulias, A Argiris, ...
Journal of immunological methods 381 (1-2), 14-22, 2012
|Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial|
DE Heron, RL Ferris, M Karamouzis, RS Andrade, EL Deeb, S Burton, ...
International Journal of Radiation Oncology* Biology* Physics 75 (5), 1493-1500, 2009
|Neck dissection in the combined‐modality therapy of patients with locoregionally advanced head and neck cancer|
A Argiris, KM Stenson, BE Brockstein, BB Mittal, H Pelzer, MS Kies, ...
Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2004
|Staging and clinical prognostic factors for small-cell lung cancer|
A Argiris, JR Murren
Cancer Journal 7 (5), 437-447, 2001
|Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and …|
A Argiris, DE Heron, RP Smith, S Kim, MK Gibson, SY Lai, BF Branstetter, ...
Journal of clinical oncology 28 (36), 5294, 2010
|Evaluating the supportive care costs of severe radiochemotherapy‐induced mucositis and pharyngitis: results from a Northwestern University Costs of Cancer Program pilot study …|
NJ Nonzee, NA Dandade, T Markossian, M Agulnik, A Argiris, JD Patel, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
|A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer|
MQ Baggstrom, Y Qi, M Koczywas, A Argiris, EA Johnson, MJ Millward, ...
Journal of Thoracic Oncology 6 (10), 1757-1760, 2011
|Phase II study of everolimus (RAD001) in previously treated small cell lung cancer|
A Tarhini, A Kotsakis, W Gooding, Y Shuai, D Petro, D Friedland, ...
Clinical Cancer Research 16 (23), 5900-5907, 2010
|A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer|
A Argiris, E Cohen, T Karrison, B Esparaz, A Mauer, R Ansari, S Wong, ...
Cancer biology & therapy 5 (7), 766-770, 2006
|Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck|
A Argiris, AP Kotsakis, T Hoang, FP Worden, P Savvides, MK Gibson, ...
Annals of oncology 24 (1), 220-225, 2013